biotech · Autoimmune Diseases
Connect Biopharm
Connect Biopharm drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Connect Biopharm pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Connect Biopharm drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.